...
首页> 外文期刊>Emerging Infectious Diseases >Public Health–Driven Research and Innovation for Next-Generation Influenza Vaccines, European Union
【24h】

Public Health–Driven Research and Innovation for Next-Generation Influenza Vaccines, European Union

机译:欧盟下一代流感疫苗的公共卫生驱动研究与创新

获取原文
           

摘要

Influenza virus infections are a major public health threat. Vaccination is available, but unpredictable antigenic changes in circulating strains require annual modification of seasonal influenza vaccines. Vaccine effectiveness has proven limited, particularly in certain groups, such as the elderly. Moreover, preparedness for upcoming pandemics is challenging because we can predict neither the strain that will cause the next pandemic nor the severity of the pandemic. The European Union fosters research and innovation to develop novel vaccines that evoke broadly protective and long-lasting immune responses against both seasonal and pandemic influenza, underpinned by a political commitment to global public health.
机译:流感病毒感染是主要的公共卫生威胁。可以进行疫苗接种,但是循环株中不可预测的抗原变化需要每年对季节性流感疫苗进行修改。事实证明,疫苗的有效性是有限的,尤其是在某些人群中,例如老年人。此外,为即将到来的大流行做好准备具有挑战性,因为我们既无法预测将导致下一次大流行的毒株,也无法预测大流行的严重程度。欧洲联盟促进研究和创新,以开发新颖的疫苗,这种疫苗可引起对季节性和大流行性流感的广泛保护和持久的免疫反应,这得益于对全球公共卫生的政治承诺。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号